Showing 1681-1690 of 21416 results for "".
- Early-Life Respiratory Infections and Maternal Allergy: Driving Factors in Childhood Asthmahttps://reachmd.com/news/early-life-respiratory-infections-and-maternal-allergy-driving-factors-in-childhood-asthma/2484834/Neonatal RSV exposure combined with maternal allergic disease is associated with a higher risk of childhood asthma—indicating that specific early-life exposures can materially alter la
- Systemic Inflammation and Depression: Clinical Implications and Emerging Therapieshttps://reachmd.com/news/systemic-inflammation-depression/2484848/A systematic review and meta-analysis in the American Journal of Psychiatry found that targeted anti-inflammatory therapy reduced overall depressive symptom severity a
- Clinical Advances in Retinal Implants: Phase IIb Trial of CPCB-RPE1 for Advanced AMDhttps://reachmd.com/news/clinical-advances-in-retinal-implants-phase-iib-trial-of-cpcb-rpe1-for-advanced-amd/2484862/Regenerative Patch Technologies has launched a Phase IIb trial of the
- Initiation of PF614 Phase 3 Trial: A New Chapter in Opioid Safetyhttps://reachmd.com/news/pf614-phase-3-trial-opioid-safety/2484846/Ensysce Biosciences has initiated a phase 3 trial of PF614,
- Therapeutic Advances in IgA Nephropathy: Atacicept and B-Cell Modulationhttps://reachmd.com/news/iga-nephropathy-atacicept-b-cell-modulation/2484843/Atacicept for the treatment of IgAN has entered the FDA accelerated Biologics License Application pathw
- Update on Ianalumab and Eltrombopag: Phase III Findings and Implicationshttps://reachmd.com/news/ianalumab-eltrombopag-phase-iii/2484864/The phase 3 VAYHIT2 trial showed that ianalumab plus eltrombopag meaningfully
- Serum Mrp8/14 Levels as a Prognostic Tool in Sepsis-Induced ARDShttps://reachmd.com/news/serum-mrp814-prognostic-sepsis-ards/2484845/In a retrospective cohort analysis, Mrp8/14 (calprotectin) levels were associated with increased ICU mortality in patients with sepsis-induced pulmonary ARDS, offering an objective admission-ti
- The Role of IncC Plasmids in Antimicrobial Resistance: Implications from the Genomic Study of Providencia stuartiihttps://reachmd.com/news/incc-plasmids-antimicrobial-resistance/2484816/NDM-1 producing Providencia stuartii isolates were identified carrying plasmid-driven carbapenemase determinants that sharply narrow therapeutic options in hospitalized patients. Whole-g
- FDA Regulatory Moves and Their Impact on Urologic Therapeautics: A Case of Detalimogenehttps://reachmd.com/news/fda-regulatory-moves-and-their-impact-on-urologic-therapeautics-a-case-of-detalimogene/2484820/The FDA selected detalimogene for its Manufacturing Readiness Program, advancing regulatory alignment for this non
- Robotic vs. Laparoscopic Roux-en-Y Gastric Bypass: Insights from the MBSAQIP Databasehttps://reachmd.com/news/robotic-laparoscopic-roux-en-y-gastric-bypass/2484817/A Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (2020–2023) registry analysis shows equivalent 30-day complication rates for robotic and lapar